{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:21:22Z","timestamp":1791724882591,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["108-2314-B-002-191-MY3"],"award-info":[{"award-number":["108-2314-B-002-191-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2113-M-001-020-MY3"],"award-info":[{"award-number":["110-2113-M-001-020-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.mcpro.2023.100624","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T20:00:55Z","timestamp":1690228855000},"page":"100624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["EGFR-T790M Mutation\u2013Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Pei-Shan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-4569","authenticated-orcid":false,"given":"Miao-Hsia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jye-Chian","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcpro.2023.100624_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jso.24532","article-title":"Lung cancer\u2014a global perspective","volume":"115","author":"McIntyre","year":"2017","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.mcpro.2023.100624_bib2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mcpro.2023.100624_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.02.001","article-title":"Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures","volume":"174","author":"Lee","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mcpro.2023.100624_bib4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.mcpro.2023.100624_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI\u2013targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mcpro.2023.100624_bib6","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.2147\/OTT.S94745","article-title":"Next-generation EGFR\/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.mcpro.2023.100624_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2018.01.005","article-title":"Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: long-term follow-up of a large patient cohort","volume":"117","author":"Okamoto","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.mcpro.2023.100624_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","volume":"11","author":"Camidge","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mcpro.2023.100624_bib9","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"Yun","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2023.100624_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1535-7163.MCT-16-0105","article-title":"Strategies to overcome bypass mechanisms mediating clinical resistance to EGFR tyrosine kinase inhibition in lung cancer","volume":"16","author":"Husain","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mcpro.2023.100624_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","article-title":"Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer","volume":"121","author":"Leonetti","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mcpro.2023.100624_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14728222.2017.1272582","article-title":"Targeting the EGFR T790M mutation in non-small-cell lung cancer","volume":"21","author":"Normanno","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.mcpro.2023.100624_bib13","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1158\/1078-0432.CCR-17-2961","article-title":"Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance","volume":"24","author":"Yu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mcpro.2023.100624_bib14","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1039\/C7SC04761D","article-title":"L718Q mutant EGFR escapes covalent inhibition by stabilizing a non-reactive conformation of the lung cancer drug osimertinib","volume":"9","author":"Callegari","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.mcpro.2023.100624_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.09.053","article-title":"A\u00a0human interactome in three quantitative dimensions organized by stoichiometries and abundances","volume":"163","author":"Hein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2023.100624_bib16","article-title":"The OncoPPi network of cancer-focused protein\u2013protein interactions to inform biological insights and therapeutic strategies","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2023.100624_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002709","article-title":"Disease-associated mutations disrupt functionally important regions of intrinsic protein disorder","volume":"8","author":"Vacic","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cell.2018.08.059","article-title":"Human diseases from gain-of-function mutations in disordered protein regions","volume":"175","author":"Li","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2023.100624_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.tibtech.2016.02.014","article-title":"Characterizing protein\u2013protein interactions using mass spectrometry: challenges and opportunities","volume":"34","author":"Smits","year":"2016","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.mcpro.2023.100624_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101693","article-title":"Endogenous protein interactomes resolved through immunoprecipitation-coupled quantitative proteomics in cell lines","volume":"3","author":"Kumar","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.mcpro.2023.100624_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cell.2019.09.008","article-title":"Oncogenic mutations rewire signaling pathways by switching protein recruitment to phosphotyrosine sites","volume":"179","author":"Lundby","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2023.100624_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/msb.2013.61","article-title":"Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms","volume":"9","author":"Li","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molcel.2016.12.004","article-title":"A\u00a0global analysis of the receptor tyrosine kinase-protein phosphatase interactome","volume":"65","author":"Yao","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcpro.2023.100624_bib24","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1074\/mcp.M114.038596","article-title":"Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress","volume":"13","author":"Tong","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mcpro.2023.100624_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejps.2016.04.025","article-title":"Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer \u2013 proof of concept towards a systems pharmacology approach","volume":"94","author":"Saafan","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.mcpro.2023.100624_bib26","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/pmic.201000650","article-title":"Abacus: a computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis","volume":"11","author":"Fermin","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2023.100624_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification\u2013mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2023.100624_bib28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nmeth.3472","article-title":"Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation","volume":"12","author":"Marcon","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.mcpro.2023.100624_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MD.0b013e31821a16f4","article-title":"Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations","volume":"90","author":"Wu","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.mcpro.2023.100624_bib30","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.1507329112","article-title":"Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition","volume":"112","author":"Yen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcpro.2023.100624_bib31","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/pmic.201300154","article-title":"Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics","volume":"13","author":"Foerster","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.mcpro.2023.100624_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092151","article-title":"Quantification and kinetic analysis of Grb2-EGFR interaction on micro-patterned surfaces for the characterization of EGFR-modulating substances","volume":"9","author":"Lanzerstorfer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2023.100624_bib33","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/nprot.2016.140","article-title":"Deep interactome profiling of membrane proteins by co-interacting protein identification technology","volume":"11","author":"Pankow","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcpro.2023.100624_bib34","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1074\/mcp.M800203-MCP200","article-title":"Significance analysis of spectral count data in label-free shotgun proteomics","volume":"7","author":"Choi","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mcpro.2023.100624_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4046\/trd.2016.79.4.248","article-title":"Mechanisms of epidermal growth factor receptor tyrosine kinase inhibitor resistance and strategies to overcome resistance in lung adenocarcinoma","volume":"79","author":"Chang","year":"2016","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"key":"10.1016\/j.mcpro.2023.100624_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/msb.2011.99","article-title":"Differential network biology","volume":"8","author":"Ideker","year":"2012","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2023.100624_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tcb.2015.12.006","article-title":"Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications","volume":"26","author":"Tan","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12935-016-0301-x","article-title":"Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes","volume":"16","author":"Peng","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.mcpro.2023.100624_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2018.04.014","article-title":"Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation","volume":"52","author":"Keller","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.mcpro.2023.100624_bib42","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1126\/science.274.5295.2086","article-title":"Control of EGF receptor signaling by clathrin-mediated endocytosis","volume":"274","author":"Vieira","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.mcpro.2023.100624_bib43","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1038\/onc.2010.157","article-title":"Nuclear trafficking of the epidermal growth factor receptor family membrane proteins","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2023.100624_bib44","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M109.000760","article-title":"Epidermal growth factor receptor translocation to the mitochondria: regulation and effect","volume":"284","author":"Demory","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2023.100624_bib45","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/brv.12515","article-title":"Molecular interplay of autophagy and endocytosis in human health and diseases","volume":"94","author":"Mahapatra","year":"2019","journal-title":"Biol. Rev."},{"key":"10.1016\/j.mcpro.2023.100624_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bies.201200130","article-title":"Endocytosis and autophagy: shared machinery for degradation","volume":"35","author":"Lamb","year":"2013","journal-title":"Bioessays"},{"key":"10.1016\/j.mcpro.2023.100624_bib47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1242\/jcs.196352","article-title":"New insights into autophagosome\u2013lysosome fusion","volume":"130","author":"Nakamura","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.mcpro.2023.100624_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112665","article-title":"PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K\/FOXO3a pathway","volume":"148","author":"Du","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mcpro.2023.100624_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2014.11.051","article-title":"NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins","volume":"557","author":"Goel","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.mcpro.2023.100624_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12964-018-0291-5","article-title":"USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells","volume":"16","author":"McCann","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.mcpro.2023.100624_bib51","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/s41467-019-09437-x","article-title":"USP32 regulates late endosomal transport and recycling through deubiquitylation of Rab7","volume":"10","author":"Sapmaz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mcpro.2023.100624_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cells7110215","article-title":"Revisiting Rab7 functions in mammalian autophagy: rab7 knockout studies","volume":"7","author":"Kuchitsu","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.mcpro.2023.100624_bib53","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2147\/OTT.S66502","article-title":"Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives","volume":"7","author":"Cheng","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.mcpro.2023.100624_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/cancers11070923","article-title":"Intrinsic resistance to EGFR-tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: differences and similarities with acquired resistance","volume":"11","author":"Santoni-Rugiu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2023.100624_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-020-01510-w","article-title":"The next tier of EGFR resistance mutations in lung cancer","volume":"40","author":"Tumbrink","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2023.100624_bib56","first-page":"3887","article-title":"Prognostic value of EGFR 19-del and 21-L858R mutations in patients with non-small cell lung cancer","volume":"18","author":"Hong","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.mcpro.2023.100624_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cell.2018.08.019","article-title":"Mutations in disordered regions can cause disease by creating dileucine motifs","volume":"175","author":"Meyer","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mcpro.2023.100624_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/cancers9040027","article-title":"EGFR family members' regulation of autophagy is at a crossroads of cell survival and death in cancer","volume":"9","author":"Henson","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mcpro.2023.100624_bib59","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/ijc.31398","article-title":"Targeting EGFR-mediated autophagy as a potential strategy for cancer therapy","volume":"143","author":"Sooro","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mcpro.2023.100624_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib61","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41589-021-00768-9","article-title":"Small molecule probes for targeting autophagy","volume":"17","author":"Whitmarsh-Everiss","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib62","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1038\/onc.2008.288","article-title":"The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11","volume":"27","author":"Chen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2023.100624_bib63","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/onc.2009.162","article-title":"WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.mcpro.2023.100624_bib64","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1074\/jbc.M113.529461","article-title":"Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized \u03b1-synuclein","volume":"289","author":"Sugeno","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2023.100624_bib65","doi-asserted-by":"crossref","first-page":"17467","DOI":"10.1074\/jbc.M116.726083","article-title":"NEDD4L protein catalyzes ubiquitination of PIK3CA protein and regulates PI3K-AKT signaling","volume":"291","author":"Wang","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mcpro.2023.100624_bib66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2018.09.004","article-title":"Roles of ubiquitin in autophagy and cell death","volume":"93","author":"G\u00f3mez-D\u00edaz","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mcpro.2023.100624_bib67","first-page":"91","article-title":"Molecular functions of NEDD4 E3 ubiquitin ligases in cancer","volume":"1856","author":"Zou","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcpro.2023.100624_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081514","article-title":"NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling","volume":"8","author":"Tanksley","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2023.100624_bib69","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/jog.12808","article-title":"Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue","volume":"41","author":"Yang","year":"2015","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"key":"10.1016\/j.mcpro.2023.100624_bib70","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1038\/s41598-019-41395-8","article-title":"Dysregulated redox regulation contributes to nuclear EGFR localization and pathogenicity in lung cancer","volume":"9","author":"Little","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcpro.2023.100624_bib71","doi-asserted-by":"crossref","first-page":"37349","DOI":"10.18632\/oncotarget.5736","article-title":"Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC","volume":"6","author":"Che","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mcpro.2023.100624_bib72","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.jtho.2019.06.014","article-title":"Molecular mechanisms of tyrosine kinase inhibitor resistance induced by membranous\/cytoplasmic\/nuclear translocation of epidermal growth factor receptor","volume":"14","author":"Rong","year":"2019","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.mcpro.2023.100624_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5603\/FHC.a2017.0007","article-title":"Inhibition of EGFR nuclear shuttling decreases irradiation resistance in HeLa cells","volume":"55","author":"Wei","year":"2017","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.mcpro.2023.100624_bib74","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/JTO.0b013e31828c7210","article-title":"The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib","volume":"8","author":"Zou","year":"2013","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.mcpro.2023.100624_bib75","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/labinvest.2013.102","article-title":"Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells","volume":"93","author":"Sakuma","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mcpro.2023.100624_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076503","article-title":"Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer","volume":"8","author":"Dragowska","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mcpro.2023.100624_bib77","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ijms18061279","article-title":"Targeting autophagy in cancer: update on clinical trials and novel inhibitors","volume":"18","author":"Chude","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcpro.2023.100624_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41427-022-00422-3","article-title":"Autophagy-targeted nanoparticles for effective cancer treatment: advances and outlook","volume":"14","author":"Long","year":"2022","journal-title":"NPG Asia Mater."}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947623001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947623001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:14:18Z","timestamp":1761527658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947623001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1535947623001354"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpro.2023.100624","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR-T790M Mutation\u2013Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpro.2023.100624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100624"}}